TW232692B - - Google Patents

Info

Publication number
TW232692B
TW232692B TW082103823A TW82103823A TW232692B TW 232692 B TW232692 B TW 232692B TW 082103823 A TW082103823 A TW 082103823A TW 82103823 A TW82103823 A TW 82103823A TW 232692 B TW232692 B TW 232692B
Authority
TW
Taiwan
Application number
TW082103823A
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of TW232692B publication Critical patent/TW232692B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW082103823A 1992-06-18 1993-05-15 TW232692B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90038492A 1992-06-18 1992-06-18

Publications (1)

Publication Number Publication Date
TW232692B true TW232692B (zh) 1994-10-21

Family

ID=25412426

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082103823A TW232692B (zh) 1992-06-18 1993-05-15

Country Status (11)

Country Link
US (1) US5281716A (zh)
EP (1) EP0575069A1 (zh)
JP (1) JPH0656841A (zh)
KR (1) KR940000463A (zh)
CN (1) CN1082043A (zh)
CA (1) CA2096667A1 (zh)
FI (1) FI932770A (zh)
HU (1) HUT68401A (zh)
IL (1) IL105779A0 (zh)
MX (1) MX9303573A (zh)
TW (1) TW232692B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
KR101633747B1 (ko) * 2015-08-10 2016-06-27 현대위아 주식회사 별치형 공구교환 장치
CN111432817B (zh) * 2017-11-29 2023-10-31 凡德贝尔大学 抑制肿瘤移转的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease

Also Published As

Publication number Publication date
CN1082043A (zh) 1994-02-16
CA2096667A1 (en) 1993-12-19
HUT68401A (en) 1995-06-28
HU9301796D0 (en) 1993-09-28
MX9303573A (es) 1994-01-31
IL105779A0 (en) 1993-09-22
US5281716A (en) 1994-01-25
KR940000463A (ko) 1994-01-03
FI932770A (fi) 1993-12-19
EP0575069A1 (fr) 1993-12-22
FI932770A0 (fi) 1993-06-16
JPH0656841A (ja) 1994-03-01

Similar Documents

Publication Publication Date Title
DK0634000T3 (zh)
DK0598561T3 (zh)
DK0613608T3 (zh)
DK0551248T3 (zh)
DK0603481T3 (zh)
DK0599160T3 (zh)
DK0574087T3 (zh)
DK0644844T3 (zh)
DK0596750T3 (zh)
BR9207065A (zh)
DK0632741T3 (zh)
DK0553681T3 (zh)
DK0574276T3 (zh)
DK0564197T3 (zh)
DK0596569T3 (zh)
DK0576097T3 (zh)
BR9202713C1 (zh)
DK0590732T3 (zh)
DE9207553U1 (zh)
BR9304980A (zh)
AU2053892A (zh)
AU2619992A (zh)
AU639201B1 (zh)
AU634461B1 (zh)
CA2087658E (zh)